[Multimodality treatment in high-risk and very high-risk prostate cancer: outcomes from international phase III randomized controlled trials].
Saved in:
| Title: | [Multimodality treatment in high-risk and very high-risk prostate cancer: outcomes from international phase III randomized controlled trials]. |
|---|---|
| Transliterated Title: | Multimodale Therapieansätze beim Hochrisikoprostatakarzinom – was wann? |
| Authors: | Mathier E; Department of Radiation Oncology, Inselspital, Bern University, Freiburgstr. 10, 3010, Bern, Schweiz., Heusel A; Department of Radiation Oncology, Inselspital, Bern University, Freiburgstr. 10, 3010, Bern, Schweiz., Shelan M; Department of Radiation Oncology, Inselspital, Bern University, Freiburgstr. 10, 3010, Bern, Schweiz. mohamed.shelan@insel.ch. |
| Source: | Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al] [Strahlenther Onkol] 2022 Oct; Vol. 198 (10), pp. 962-965. Date of Electronic Publication: 2022 Jun 22. |
| Publication Type: | Clinical Trial, Phase III; Journal Article; Randomized Controlled Trial |
| Journal Info: | Publisher: Urban & Vogel Country of Publication: Germany NLM ID: 8603469 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1439-099X (Electronic) Linking ISSN: 01797158 NLM ISO Abbreviation: Strahlenther Onkol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
